Blackhawk Capital Partners Llc. Gsk PLC Transaction History

Blackhawk Capital Partners Llc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$34.07 - $39.94 $1.08 Million - $1.26 Million	-31,604 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$38.11 - $42.99 $50,876 - $57,391	1,335 Added 4.41%	31,604 $1.29 Million
Q2 2020 Aug 04, 2020	SELL	$37.87 - $43.58 $1,249 - $1,438	-33 Reduced 0.11%	30,269 $1.15 Million
Q1 2020 Apr 03, 2020	SELL	$32.47 - $48.83 $55,296 - $83,157	-1,703 Reduced 5.32%	30,302 $1.42 Million
Q4 2019 Feb 07, 2020	BUY	$42.0 - $48.25 $5,754 - $6,610	137 Added 0.43%	32,005 $1.37 Million
Q3 2019 Nov 08, 2019	BUY	$40.46 - $43.52 $33,339 - $35,860	824 Added 2.65%	31,868 $1.36 Million
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $1.22 Million - $1.33 Million	31,044 New	31,044 $1.24 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.1B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.